Assembly Biosciences Inc
NASDAQ:ASMB

Watchlist Manager
Assembly Biosciences Inc Logo
Assembly Biosciences Inc
NASDAQ:ASMB
Watchlist
Price: 13.52 USD -0.29% Market Closed
Market Cap: 103.3m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

ASMB Price Targets Summary
Assembly Biosciences Inc

Wall Street analysts forecast ASMB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ASMB is 34.68 USD with a low forecast of 31.31 USD and a high forecast of 37.8 USD.

ASMB Lowest Forecast
Wall Street Target
31.31 USD
132% Upside
ASMB Average Forecast
Wall Street Target
34.68 USD
157% Upside
ASMB Highest Forecast
Wall Street Target
37.8 USD
180% Upside
Lowest
Price Target
31.31 USD
132% Upside
Average
Price Target
34.68 USD
157% Upside
Highest
Price Target
37.8 USD
180% Upside
Assembly Biosciences Inc Competitors:
Price Targets
NBIX
Neurocrine Biosciences Inc
32% Upside
CUV
Clinuvel Pharmaceuticals Ltd
149% Upside
SRZN
Surrozen Inc
374% Upside
BSLN
Basilea Pharmaceutica AG
105% Upside
NBIX
Neurocrine Biosciences Inc
32% Upside
CUV
Clinuvel Pharmaceuticals Ltd
149% Upside
SRZN
Surrozen Inc
374% Upside
BSLN
Basilea Pharmaceutica AG
105% Upside
RAPT
Rapt Therapeutics Inc
315% Upside
B
251120
Bio-FD&C Co Ltd
25% Upside
INCY
Incyte Corp
18% Upside
S
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
33% Downside

Revenue
Forecast

Revenue Estimate
Assembly Biosciences Inc

The compound annual growth rate of Assembly Biosciences Inc's revenue for the next 3 years is 29%.

N/A
Past Growth
29%
Estimated Growth
Estimates Accuracy
-11%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Assembly Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Assembly Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-57%
Average Miss
What are analyst estimates?

See Also

Summary
ASMB intrinsic value, competitors valuation, and company profile.
DCF Valuation
ASMB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ASMB stock valuation using valuation multiples.
Wall Street Estimates
ASMB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ASMB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ASMB's stock price target?
Price Target
34.68 USD

According to Wall Street analysts, the average 1-year price target for ASMB is 34.68 USD with a low forecast of 31.31 USD and a high forecast of 37.8 USD.

What is Assembly Biosciences Inc's Revenue forecast?
Projected CAGR
29%

The compound annual growth rate of Assembly Biosciences Inc's revenue for the next 3 years is 29%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 257,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.